WALTHAM, MA, March 13, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire –Tecogen Inc. (OTCQX:TGEN), a leading manufacturer of clean energy products, reported revenues of $5.9 million and a net loss of $1.8 million for the quarter ended December 31, 2023 compared to revenues of $4.5 million, and a net loss of $1.4 million in 2022. The increase in net loss was primarily driven by an increase in bad debt reserves for installation projects from 2017 an increase in reserves for obsolete inventory.
Our Adjusted EBITDA loss narrowed to $527 thousand for the quarter ended December 31, 2023 compared to $1.1 million in 2022. For the year ended December 31, 2023 revenues were $25.1 million and the net loss was $4.5 million compared to revenues of $25.0 million, and net loss of $2.4 million for the same period in 2022. For the year the Adjusted EBITDA loss was $2.6 million in 2023 and $1.7 million in 2022.
"During the 4th quarter we had positive cash flow from operations and a recovery in gross margin for our Services segment. We continue to execute on our strategy of increasing recurring cash flow from Energy and Services to cover our fixed costs. This will allow us to be cash flow positive while we secure profitable large dollar value projects.
Unlike in the past where our sales were predominantly small cogeneration projects for residential buildings in New York City, we are now seeing the market shift to multiple unit chiller and cogeneration projects nationwide. We recently received a 6 unit (3 hybrid chillers and 3 Inverde cogeneration units) as well as a 12 unit cogeneration order. We are now focused on securing additional multiple unit product orders that we expect will result in sustained profitability and growth. In fact, we are specified on large chiller projects for some iconic facilities that are on track to close later this year.
We are also receiving significant interest from customers who are limited in electrical capacity or facing sharp increases in peak electricity charges. We expect customer pain point to increase as electrification efforts place higher pressure on the ability of utilities to supply sufficient power. As a result, our proprietary software and utility demand response capabilities will give us a competitive advantage in securing new product orders and increased Services revenue.
Although we showed a significant net loss in Q4, this was driven by a $1 million increase in bad debt expense associated with old installation project receivables and obsolete inventory. We also performed much needed work on replacing engines in the Services fleet and site improvement work within our energy fleet. These costs and the obsolete inventory reserve drove down gross profit margins but are an essential investment to improve unit runtime going forward.
We have $1 million remaining on our credit line which will help us execute our factory move later this quarter, and our present cash position of $1.1 million," commented Abinand Rangesh, Tecogen's Chief Executive Officer.
Key Takeaways
Revenues
Net Loss and Earnings Per Share
Loss from Operations
Gross Profit and Gross Margin
Operating Expenses
Adjusted EBITDA(1) was negative $527 thousand for the fourth quarter of 2023 compared to negative $1.1 million for the fourth quarter of 2022. Adjusted EBITDA(1) was negative $2.6 million for the year ended December 31, 2023 compared to negative $1.7 million for the comparable period in 2022. (Adjusted EBITDA is defined as net income or loss attributable to Tecogen, adjusted for interest, income taxes, depreciation and amortization, stock-based compensation expense, unrealized gain or loss on equity securities, goodwill impairment charges, inventory writedowns, bad debt provision and other non-cash non-recurring charges or gains including abandonment of intangible assets and the extinguishment of debt. See the table following the Condensed Consolidated Statements of Operations for a reconciliation from net income (loss) to Adjusted EBITDA, as well as important disclosures about the company's use of Adjusted EBITDA).
Conference Call Scheduled for March 14, 2024, at 9:30 am ET
Tecogen will host a conference call on March 14, 2024 to discuss the fourth quarter results beginning at 9:30 AM eastern time. To listen to the call please dial (877) 407-7186 within the U.S. and Canada, or (201) 689-8052 from other international locations. Participants should ask to be joined to the Tecogen Fourth Quarter 2023 earnings call. Please begin dialing 10 minutes before the scheduled starting time. The earnings press release will be available on the Company website at www.Tecogen.com in the "News and Events" section under "About Us." The earnings conference call will be webcast live. To view the associated slides, register for and listen to the webcast, go to https://ir.tecogen.com/ir-calendar. Following the call, the recording will be archived for 14 days.
The earnings conference call will be recorded and available for playback one hour after the end of the call. To listen to the playback, dial (877) 660-6853 within the U.S. and Canada, or (201) 612-7415 from other international locations and use Conference Call ID#: 13672659.
About Tecogen
Tecogen Inc. designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company provides cost effective, environmentally friendly and reliable products for energy production that nearly eliminate criteria pollutants and significantly reduce a customer’s carbon footprint.
In business for over 35 years, Tecogen has shipped more than 3,200 units, supported by an established network of engineering, sales, and service personnel across the United States. For more information, please visit www.tecogen.com or contact us for a free Site Assessment.
Tecogen, InVerde e+, Tecochill, Tecopower, Tecofrost, Tecopack, and Ultera are registered trademarks of Tecogen Inc.
Forward Looking Statements
This press release and any accompanying documents, contain “forward-looking statements” which may describe strategies, goals, outlooks or other non-historical matters, or projected revenues, income, returns or other financial measures, that may include words such as "believe," "expect," "anticipate," "intend," "plan," "estimate," "project," "target," "potential," "will," "should," "could," "likely," or "may" and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements.
In addition to those factors described in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and on our Form 8-K, under “Risk Factors”, among the factors that could cause actual results to differ materially from past and projected future results are the following: fluctuations in demand for our products and services, competing technological developments, issues relating to research and development, the availability of incentives, rebates, and tax benefits relating to our products and services, changes in the regulatory environment relating to our products and services, integration of acquired business operations, and the ability to obtain financing on favorable terms to fund existing operations and anticipated growth.
In addition to GAAP financial measures, this press release includes certain non-GAAP financial measures, including adjusted EBITDA which excludes certain expenses as described in the presentation. We use Adjusted EBITDA as an internal measure of business operating performance and believe that the presentation of non-GAAP financial measures provides a meaningful perspective of the underlying operating performance of our current business and enables investors to better understand and evaluate our historical and prospective operating performance by eliminating items that vary from period to period without correlation to our core operating performance and highlights trends in our business that may not otherwise be apparent when relying solely on GAAP financial measures.
Tecogen Media & Investor Relations Contact Information:
Abinand Rangesh
P: 781-466-6487
E: This email address is being protected from spambots. You need JavaScript enabled to view it.
TECOGEN INC
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited)
December 31, 2023 | December 31, 2022 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 1,351,270 | $ | 1,913,969 | |||
Accounts receivable, net | 6,735,337 | 6,714,122 | |||||
Employee retention credit receivable | 46,147 | 713,269 | |||||
Unbilled revenue | 1,258,532 | 1,805,330 | |||||
Inventory, net | 10,553,419 | 10,482,729 | |||||
Prepaid and other current assets | 360,639 | 401,189 | |||||
Total current assets | 20,305,344 | 22,030,608 | |||||
Property, plant and equipment, net | 1,162,577 | 1,407,720 | |||||
Right of use assets | 943,283 | 1,245,549 | |||||
Intangible assets, net | 2,436,230 | 997,594 | |||||
Goodwill | 2,743,424 | 2,406,156 | |||||
Other assets | 201,771 | 165,230 | |||||
TOTAL ASSETS | $ | 27,792,629 | $ | 28,252,857 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Related party loan | $ | 505,505 | $ | — | |||
Accounts payable | 4,514,415 | 3,261,952 | |||||
Accrued expenses | 2,504,629 | 2,384,447 | |||||
Deferred revenue, current | 1,647,206 | 1,115,627 | |||||
Lease obligations, current | 289,473 | 687,589 | |||||
Acquisition liabilities, current | 845,363 | — | |||||
Unfavorable contract liabilities, current | 176,207 | 236,705 | |||||
Total current liabilities | 10,482,798 | 7,686,320 | |||||
Long-term liabilities: | |||||||
Deferred revenue, net of current portion | 369,611 | 371,823 | |||||
Lease obligations, net of current portion | 683,307 | 623,452 | |||||
Acquisition liabilities, net of current portion | 1,181,779 | — | |||||
Unfavorable contract liability, net of current portion | 422,839 | 583,512 | |||||
Total liabilities | 13,140,334 | 9,265,107 | |||||
Stockholders’ equity: | |||||||
Tecogen Inc. shareholders’ equity: | |||||||
Common stock, $0.001 par value; 100,000,000 shares authorized; 24,850,261 and 24,850,261 issued and outstanding at December 31, 2023 and 2022, respectively | 24,850 | 24,850 | |||||
Additional paid-in capital | 57,601,402 | 57,351,008 | |||||
Accumulated deficit | (42,879,656) | (38,281,548) | |||||
Total Tecogen Inc. stockholders’ equity | 14,746,596 | 19,094,310 | |||||
Noncontrolling interest | (94,301) | (106,560) | |||||
Total stockholders’ equity | 14,652,295 | 18,987,750 | |||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 27,792,629 | $ | 28,252,857 |
TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
Three Months Ended | |||||||
December 31, 2023 | December 31, 2022 | ||||||
Revenues | |||||||
Products | $ | 1,765,390 | $ | 999,771 | |||
Services | 3,591,310 | 3,014,586 | |||||
Energy production | 541,613 | 517,230 | |||||
5,898,313 | 4,531,587 | ||||||
Cost of sales | |||||||
Products | 1,422,325 | 678,855 | |||||
Services | 1,749,347 | 1,202,800 | |||||
Energy production | 377,379 | 270,693 | |||||
Gross Profit | 3,549,051 | 2,152,348 | |||||
Operating expenses | 2,349,262 | 2,379,239 | |||||
General and administrative | 3,461,807 | 3,267,067 | |||||
Selling | 504,716 | 238,863 | |||||
Research and Development | 214,320 | 195,747 | |||||
Gain on sale of assets | (16,257 | ) | — | ||||
Long-lived asset impairment | — | 76,049 | |||||
Total operating expenses | 4,164,586 | 3,777,726 | |||||
Loss from operations | (1,815,324 | ) | (1,398,487 | ) | |||
Other income (expense) | |||||||
Interest and other income (expense) | (24,442 | ) | (12,157 | ) | |||
Interest expense | (7,421 | ) | (415 | ) | |||
Unrealized loss on investment securities | 18,749 | (18,749 | ) | ||||
Total other expense, net | (13,114 | ) | (31,321 | ) | |||
Loss before income taxes | (1,828,438 | ) | (1,429,808 | ) | |||
Income tax provision | 239 | — | |||||
Consolidated net loss | (1,828,677 | ) | (1,429,808 | ) | |||
Income attributable to the noncontrolling interest | (17,720 | ) | 5,402 | ||||
Net loss attributable to Tecogen Inc | (1,846,397 | ) | (1,424,406 | ) | |||
Net loss per share - basic | $ | (0.07 | ) | $ | (0.06 | ) | |
Weighted average shares outstanding - basic | 24,850,261 | 24,850,261 | |||||
Net loss per share - diluted | $ | (0.07 | ) | $ | (0.06 | ) | |
Weighted average shares outstanding - diluted | 24,850,261 | 24,850,261 |
Three Months Ended | |||||||
December 31, 2023 | December 31, 2022 | ||||||
Non-GAAP financial disclosure (1) | |||||||
Net loss attributable to Tecogen Inc | $ | (1,846,397) | $ | (1,424,406) | |||
Interest expense, net | 7,421 | 415 | |||||
Provision for income taxes | 239 | — | |||||
Depreciation and amortization, net | 107,933 | 103,381 | |||||
EBITDA | (1,730,804) | (1,320,610) | |||||
Stock-based compensation | 75,683 | 79,431 | |||||
Unrealized loss on securities | (18,749) | 18,749 | |||||
Inventory write down | 402,883 | — | |||||
Long-lived asset impairment | — | 76,049 | |||||
Bad debt provision | 744,248 | — | |||||
Adjusted EBITDA | $ | (526,739) | $ | (1,146,381) |
TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
Years Ended | |||||||
December 31, 2023 | December 31, 2022 | ||||||
Revenues | |||||||
Products | $ | 8,859,946 | $ | 11,156,099 | |||
Services | 14,523,054 | 12,060,661 | |||||
Energy production | 1,756,419 | 1,785,854 | |||||
25,139,419 | 25,002,614 | ||||||
Cost of sales | |||||||
Products | 5,923,096 | 7,413,320 | |||||
Services | 7,909,202 | 5,525,493 | |||||
Energy production | 1,105,503 | 996,990 | |||||
14,937,801 | 13,935,803 | ||||||
Gross profit | 10,201,618 | 11,066,811 | |||||
Operating expenses: | |||||||
General and administrative | 11,880,389 | 10,909,251 | |||||
Selling | 1,931,037 | 1,811,085 | |||||
Research and development | 840,011 | 732,873 | |||||
Gain on sale of assets | (36,207) | (41,931) | |||||
Long-lived asset impairment | — | 4,674 | |||||
Total operating expenses | 14,615,230 | 13,415,952 | |||||
Loss from operations | (4,413,612) | (2,349,141) | |||||
Other income (expense) | |||||||
Interest and other income (expense) | (61,003) | (34,713) | |||||
Interest expense | (16,050) | (16,255) | |||||
Unrealized gain on marketable securities | — | 18,749 | |||||
Total other expense, net | (77,053) | (32,219) | |||||
Loss before income taxes | (4,490,665) | (2,381,360) | |||||
State income tax provision | 32,491 | 16,352 | |||||
Consolidated net loss | (4,523,156) | (2,397,712) | |||||
Income attributable to the noncontrolling interest | (74,952) | (50,215) | |||||
Net loss attributable to Tecogen Inc. | $ | (4,598,108) | $ | (2,447,927) | |||
Net loss per share - basic | $ | (0.19) | $ | (0.10) | |||
Weighted average shares outstanding - basic | 24,850,261 | 24,850,261 | |||||
Net loss per share - diluted | $ | (0.19) | $ | (0.10) | |||
Weighted average shares outstanding -diluted | 24,850,261 | 24,850,261 |
Years Ended | |||||||
Non-GAAP financial disclosure (1) | December 31, 2023 | December 31, 2022 | |||||
Net loss attributable to Tecogen Inc | $ | (4,598,108) | $ | (2,447,927) | |||
Interest expense, net | 16,050 | 16,255 | |||||
Provision for income taxes | 32,491 | 16,352 | |||||
Depreciation and amortization, net | 567,712 | 428,348 | |||||
EBITDA | (3,981,855) | (1,986,972) | |||||
Stock-based compensation | 250,394 | 334,149 | |||||
Unrealized loss on investment securities | — | (18,749) | |||||
Inventory writedown | 402,883 | — | |||||
Long-lived asset impairment | — | 4,674 | |||||
Bad debt provision | 744,248 | — | |||||
Adjusted EBITDA | $ | (2,584,329) | $ | (1,666,898) |
(1) Non-GAAP Financial Measures
In addition to reporting net income, a U.S. generally accepted accounting principle (“GAAP”) measure, this news release contains information about Adjusted EBITDA (net income (loss) attributable to Tecogen Inc adjusted for interest, income taxes, depreciation and amortization, stock-based compensation expense, unrealized gain or loss on investment securities, goodwill impairment charges and other non-cash non-recurring charges including abandonment of certain intangible assets, extinguishment of debt, inventory writedown and bad debt provision), which is a non-GAAP measure. The Company believes Adjusted EBITDA allows investors to view its performance in a manner similar to the methods used by management and provides additional insight into its operating results. Adjusted EBITDA is not calculated through the application of GAAP. Accordingly, it should not be considered as a substitute for the GAAP measure of net income and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure. The use of any non-GAAP measure may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies.
TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
Years Ended | |||||||
December 31, 2023 | December 31, 2022 | ||||||
Consolidated loss | $ | (4,523,156) | $ | (2,397,712) | |||
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Depreciation, accretion and amortization, net | 567,712 | 428,348 | |||||
Long-lived asset impairment | — | 4,674 | |||||
Gain on sale of assets | (36,207) | (41,931) | |||||
Provision for doubtful accounts receivable | 902,432 | (70,987) | |||||
Provision for litigation | — | 150,000 | |||||
Provision for inventory reserve | 402,883 | 107,000 | |||||
Unrealized gain on investment securities | — | (18,749) | |||||
Stock-based compensation | 250,394 | 334,149 | |||||
Changes in operating assets and liabilities: | |||||||
(Increase) decrease in: | |||||||
Accounts receivable | (81,195) | 2,401,904 | |||||
Inventory, net | (82,525) | (2,824,740) | |||||
Unbilled revenue | 56,994 | 1,452,860 | |||||
Prepaid expenses and other current assets | 40,550 | 177,612 | |||||
Other non-current assets | 265,725 | 625,320 | |||||
Increase (decrease) in: | |||||||
Accounts payable | 1,161,416 | (246,401) | |||||
Accrued expenses | 128,869 | (109,282) | |||||
Deferred revenue | 543,842 | (678,758) | |||||
Other current liabilities | (421,049) | (645,236) | |||||
Net cash used in operating activities | (823,315) | (1,351,929) | |||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
Purchases of property and equipment | (46,851) | (314,879) | |||||
Proceeds on sale of property and equipment | 34,655 | 72,655 | |||||
Purchases of intangible assets | — | (29,505) | |||||
Payment for business acquisition | (170,000) | — | |||||
Distributions to noncontrolling interest | (62,693) | (76,836) | |||||
Net used in investing activities | (244,889) | (348,565) | |||||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
Proceeds from related party note | 505,505 | — | |||||
Net cash provided by financing activities | 505,505 | — | |||||
Change in cash and cash equivalents | (562,699) | (1,700,494) | |||||
Cash and cash equivalents, beginning of the year | 1,913,969 | 3,614,463 | |||||
Cash and cash equivalents, end of the year | $ | 1,351,270 | $ | 1,913,969 | |||
Supplemental disclosure of cash flow information: | |||||||
Cash paid for interest | $ | 10,926 | $ | 14,597 | |||
Cash paid for taxes | $ | 32,491 | $ | 16,352 |
Last Trade: | US$1.51 |
Daily Change: | -0.08 -5.03 |
Daily Volume: | 28,177 |
Market Cap: | US$37.520M |
December 10, 2024 November 25, 2024 November 13, 2024 August 07, 2024 |
Leveraging its vertically-integrated approach from mine to material manufacturing, Graphite One intends to produce high-grade anode material for the lithium-ion electric vehicle battery market and energy storage systems...
CLICK TO LEARN MOREElse Nutrition is changing the face of early childhood nutrition with clean, sustainable, plant-based products. The company has developed the world’s first whole plant-based infant formula that is targeting the $100+ billion global...
CLICK TO LEARN MORECOPYRIGHT ©2022 GREEN STOCK NEWS